Upadacitinib 00074-2309-99
- Manufacturer
- Abbvie Inc.
- Dosage Form
- Tablet
- Product Type
- Drug For Further Processing
- Marketing Start
- May 2, 2024
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Upadacitinib | 15 mg/1 |
Selected Package
00074-2309-99Selected30400 TABLET in 1 DRUM (0074-2309-99)